The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C

BACKGROUND: It has been found that ITPase deficiency is caused by ITPA gene polymorphisms. It was observed that ITPA polymorphisms have impact on hematological changes, including hemoglobin (Hb)-decline during treatment of chronic hepatitis C (CHC) patients with pegylated-interferon (PEG-IFN) plus r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepat Mon
Autors principals: Pouryasin, Mohammad, Keshvari, Maryam, Sharafi, Heidar, Alavian, Seyed Moayed, Behnava, Bita, Alavian, Seyed Ehsan, Pouryasin, Ali
Format: Artigo
Idioma:Inglês
Publicat: Kowsar 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4851836/
https://ncbi.nlm.nih.gov/pubmed/27148387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.35278
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars